My NCBISign In

Display Settings:

Format

Send to:

Choose Destination
    Transplant Proc. 2009 Nov;41(9):3796-9.

    Antiretroviral and immunosuppressive drug-drug interactions in human immunodeficiency virus-infected liver and kidney transplant recipients.

    Marfo K, Greenstein S.

    Source

    Department of Pharmacy and Transplant Surgery, Montefiore Medical Center, Bronx, NY, USA.

    Abstract

    Highly active antiretroviral therapy (HAART) has significantly reduced mortality, and prolonged life expectancy of human immunodeficiency virus (HIV)-positive patients. Such improvements have led to increasing numbers of HIV-infected patients with end-stage organ disease as potential candidates for transplantation. A HAART regimen usually consists of a combination of nucleoside reverse transcriptase inhibitors (NRTI), non-nucleoside reverse transcriptase inhibitors (NNRTI), and/or protease inhibitors (PI). PI are known to strongly inhibit the cytochrome P450 3A (CYP3A) enzyme system that is responsible for the metabolism of immunosuppressive drugs, such as tacrolimus, sirolimus, and cyclosporine. Besides these pharmacokinetic drug-drug interactions, potential pharmacodynamic drug-drug interactions may also occur with concomitant HAART and antimetabolites, such as mycophenolate mofetil. An approach to immunosuppressive management in HIV-infected organ transplant recipients requires attention to such complexities as unique drug-drug interactions and increased drug-related toxicities.

    PMID:
    19917390
    [PubMed - indexed for MEDLINE]

    MeSH Terms, Substances

    MeSH Terms

    Substances

    LinkOut - more resources

    Full Text Sources

    Medical

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Related citations in PubMed

      See reviews... See all...

      Cited by 2 PubMed Central articles

      • Nephrotoxicity of HAART. [AIDS Res Treat. 2011]
        Nephrotoxicity of HAART.
        Kalyesubula R, Perazella MA. AIDS Res Treat. 2011; 2011:562790. Epub 2011 Aug 15.
      • Review Potential use of rapamycin in HIV infection. [Br J Clin Pharmacol. 2010]
        Review Potential use of rapamycin in HIV infection.
        Donia M, McCubrey JA, Bendtzen K, Nicoletti F. Br J Clin Pharmacol. 2010 Dec; 70(6):784-93.

      Related information

      • Related Citations
        Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
      • Cited in PMC
        Full-text articles in the PubMed Central Database that cite the current articles.

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk